A French neurologist shares their insights on the treatment of seizures as well as developmental and epileptic encephalopathies such as Lennox-Gastaut syndrome and Dravet syndrome. They also discuss their outlook on pipeline drugs and share how the market might change in the future.

This interview was conducted on January 10, 2025.

If you are a Datamonitor Healthcare client, you may access the interview from our KOL Insight channel.

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal.

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.